Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 7 months ago
What are the take-home messages from ESC 2O23? Join us as we delve into the pivotal results that ignited debates and discussions at ESC Congress 2023. Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) return with their "View from the Thoraxcenter" review, where they analyse the hot line and late-breaking trials presented in Amsterdam. In this ESC 2023… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 8 months ago
What is hot at ESC 2023? In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) preview the hot line and late-breaking data presented at ESC Congress 2023. With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases. Top trials… View more
Research Area(s) / Expertise: Job title: Professor of Medicine
Personal History Born in London, UK, Dr Demetri Yannopoulos is one of the world’s leading researchers and advocates for the improvement of cardiac arrest care among cardiologists worldwide.4 In addition to being a Cardiologist, he is a Professor of Medicine, Research Director and Director of the Resuscitation Medicine Faculty at the University of Minnesota.1 Academic History In… View more
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 7 months ago
ESC 23 — We are joined by Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) for an insightful wrap-up of the first day of ESC Congress 2023. New data releases covered in detail include: BUDAPEST-CRT FIRE ECLS-SHOCK STOP-DAPT 3 Recorded on-site at ESC Congress 2023, Amsterdam. Editors: Mirjam Boros and Jordan Rance Video Specialists: Dan Brent, Tom… View more
Author(s): Charles Simonton , Craig Thompson , Jason R Wollmuth , et al Added: 3 years ago
Coronary artery disease (CAD) is a leading cause of morbidity and mortality globally, despite advances in medical and preventive therapy. It is estimated that 18.2 million adults in the US have CAD, with 720,000 Americans projected to have a first hospitalization for MI or CAD death this year.1 Treatment of patients with symptomatic CAD includes guideline-directed medical therapy and coronary… View more